Neuroprotective mixture for mitigating the harmful effects of ischemic stroke
AssigneeTricerapro Holding, LLC
InventorsJoseph L. Clark, Todd J. Crocco, Charles L. Rosen, Steven Cutright
Life of this patent
Estimating the term…
Abstract
A neuroprotective mixture includes Phosphocreatine (PCr), Magnesium Gluconate (MgG), and ß-hydroxybutyrate (BHB). The PCR, MgG, and BHB are combined in a 2:1:2 molar ratio of PCr:MgH:BHB. The neuroprotective mixture is a useful preventative and prophylactic supplement, which also can function to extend the post-stroke treatment window.
Claims14
A composition for prophylactically mitigating the harmful effects of stroke, the composition comprising a mixture of creatine, magnesium salt, and one or more ketone bodies selected from the groups consisting of (1) creatine monohydrate, creatine ethyl ester, creatine ethyl ester malate, creatine gluconate, creatine hydrochlorate, tri creatine malate, tri creatine orotate, and phosphocreatine, (2) magnesium gluconate, magnesium chloride, magnesium sulfate, and magnesium citrate, and (3) β-Hydroxybutyrate (BHB) and acetoacetate;
- and further wherein the creatine, magnesium salt, and one or more ketone bodies are present in a 2:1:2 ratio.
A method of mitigating the harmful effects of stroke in a person, comprising administering to that person a composition comprising a mixture of a creatine, a magnesium salt, and one or more ketone bodies, selected from the groups consisting of (1) creatine monohydrate, creatine ethyl ester, creatine ethyl ester malate, creatine gluconate, creatine hydrochlorate, tri creatine malate, tri creatine orotate, and phosphocreatine, (2) magnesium gluconate, magnesium chloride, magnesium sulfate, and magnesium citrate, and (3) β-Hydroxybutyrate (BHB) and acetoacetate;
- and further wherein the composition is administered orally on a daily basis prior to the occurrence of a stroke.
Dependencies are inferred from the claim text.